Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Atezolizumab Plus Bevacizumab in First Line NSCLC Patients

Fundación GECP · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
nsclc
non small cell lung cancer, nsclc, atezolizumab, bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 879873
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.